S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   191.69 (-0.96%)
AAPL   236.41 (+0.48%)
FB   185.85 (-2.38%)
MSFT   137.41 (-1.63%)
GOOGL   1,244.41 (-0.67%)
AMZN   1,757.51 (-1.68%)
CGC   20.21 (-2.65%)
NVDA   190.49 (-1.96%)
MU   43.47 (-4.46%)
BABA   169.13 (-4.37%)
GE   8.96 (-0.88%)
TSLA   256.95 (-1.92%)
AMD   30.97 (-0.55%)
T   38.47 (+1.75%)
F   9.29 (+1.98%)
ACB   3.68 (-5.40%)
PRI   123.53 (-0.44%)
NFLX   275.30 (-6.15%)
BAC   30.35 (+0.30%)
GILD   64.91 (-0.49%)
DIS   130.89 (-1.12%)
S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   191.69 (-0.96%)
AAPL   236.41 (+0.48%)
FB   185.85 (-2.38%)
MSFT   137.41 (-1.63%)
GOOGL   1,244.41 (-0.67%)
AMZN   1,757.51 (-1.68%)
CGC   20.21 (-2.65%)
NVDA   190.49 (-1.96%)
MU   43.47 (-4.46%)
BABA   169.13 (-4.37%)
GE   8.96 (-0.88%)
TSLA   256.95 (-1.92%)
AMD   30.97 (-0.55%)
T   38.47 (+1.75%)
F   9.29 (+1.98%)
ACB   3.68 (-5.40%)
PRI   123.53 (-0.44%)
NFLX   275.30 (-6.15%)
BAC   30.35 (+0.30%)
GILD   64.91 (-0.49%)
DIS   130.89 (-1.12%)
Log in

Pulse Biosciences News Headlines (NASDAQ:PLSE)

$15.08
+0.51 (+3.50 %)
(As of 10/18/2019 04:00 PM ET)
Today's Range
$14.20
Now: $15.08
$15.16
50-Day Range
$11.53
MA: $14.40
$16.97
52-Week Range
$8.60
Now: $15.08
$19.77
Volume76,900 shs
Average Volume56,781 shs
Market Capitalization$313.18 million
P/E RatioN/A
Dividend YieldN/A
Beta1.88

Headlines

Pulse Biosciences (NASDAQ PLSE) News Headlines

Source:
DateHeadline
PLSE.PH - Pulse Biosciences Inc Profile | ReutersPLSE.PH - Pulse Biosciences Inc Profile | Reuters
www.reuters.com - October 9 at 6:24 PM
Head to Head Comparison: Merit Medical Systems (NASDAQ:MMSI) & Pulse Biosciences (NASDAQ:PLSE)Head to Head Comparison: Merit Medical Systems (NASDAQ:MMSI) & Pulse Biosciences (NASDAQ:PLSE)
www.americanbankingnews.com - October 8 at 4:09 PM
-$0.61 Earnings Per Share Expected for Pulse Biosciences Inc (NASDAQ:PLSE) This Quarter-$0.61 Earnings Per Share Expected for Pulse Biosciences Inc (NASDAQ:PLSE) This Quarter
www.americanbankingnews.com - October 1 at 5:39 PM
Pulse Biosciences Announces Scientific Presentations of Nano-Pulse Stimulation™ Technology at Key Medical Aesthetic MeetingsPulse Biosciences Announces Scientific Presentations of Nano-Pulse Stimulation™ Technology at Key Medical Aesthetic Meetings
finance.yahoo.com - October 1 at 5:05 PM
Head to Head Comparison: Inovio Pharmaceuticals (NASDAQ:INO) and Pulse Biosciences (NASDAQ:PLSE)Head to Head Comparison: Inovio Pharmaceuticals (NASDAQ:INO) and Pulse Biosciences (NASDAQ:PLSE)
www.americanbankingnews.com - October 1 at 7:27 AM
Reviewing Tandem Diabetes Care (NASDAQ:TNDM) & Pulse Biosciences (NASDAQ:PLSE)Reviewing Tandem Diabetes Care (NASDAQ:TNDM) & Pulse Biosciences (NASDAQ:PLSE)
www.americanbankingnews.com - September 23 at 4:21 PM
Could Pulse Biosciences, Inc.'s (NASDAQ:PLSE) Investor Composition Influence The Stock Price?Could Pulse Biosciences, Inc.'s (NASDAQ:PLSE) Investor Composition Influence The Stock Price?
finance.yahoo.com - August 21 at 7:54 PM
Pulse Biosciences Announces Podium Presentation of Nano-Pulse Stimulation™ Technology at Major Aesthetic Procedures ConferencePulse Biosciences Announces Podium Presentation of Nano-Pulse Stimulation™ Technology at Major Aesthetic Procedures Conference
finance.yahoo.com - August 6 at 8:38 AM
Pulse Biosciences to Report Second Quarter 2019 Operational Highlights and Financial ResultsPulse Biosciences to Report Second Quarter 2019 Operational Highlights and Financial Results
finance.yahoo.com - July 25 at 5:47 PM
Is Pulse Biosciencess (NASDAQ:PLSE) 189% Share Price Increase Well Justified?Is Pulse Biosciences's (NASDAQ:PLSE) 189% Share Price Increase Well Justified?
finance.yahoo.com - May 23 at 6:37 PM
Is Pulse Biosciences's (NASDAQ:PLSE) 189% Share Price Increase Well Justified?Is Pulse Biosciences's (NASDAQ:PLSE) 189% Share Price Increase Well Justified?
finance.yahoo.com - May 23 at 6:37 PM
Pulse Biosciences, Inc. (PLSE) Q1 2019 Earnings Call TranscriptPulse Biosciences, Inc. (PLSE) Q1 2019 Earnings Call Transcript
finance.yahoo.com - May 8 at 9:21 AM
Pulse Bio down 20% on delay of U.S. approval of CellFX SystemPulse Bio down 20% on delay of U.S. approval of CellFX System
seekingalpha.com - May 1 at 6:33 PM
Pulse Biosciences Inc.Pulse Biosciences Inc.
www.barrons.com - May 1 at 6:33 PM
Acne And Wart Markets Will Be Key For Pulse BioSciencesAcne And Wart Markets Will Be Key For Pulse BioSciences
seekingalpha.com - April 23 at 5:34 PM
Pulse Biosciences to Report First Quarter 2019 Operational Highlights and Financial ResultsPulse Biosciences to Report First Quarter 2019 Operational Highlights and Financial Results
finance.yahoo.com - April 18 at 9:26 AM
Pulse Biosciences Announces Presentations at the 2019 American Society for Laser Medicine and Surgery Annual ConferencePulse Biosciences Announces Presentations at the 2019 American Society for Laser Medicine and Surgery Annual Conference
finance.yahoo.com - March 26 at 6:35 PM
Pulse Biosciences Appoints Mitchell Levinson to Board of Directors - Business WirePulse Biosciences Appoints Mitchell Levinson to Board of Directors - Business Wire
www.businesswire.com - March 21 at 9:23 AM
Pulse Biosciences Appoints Mitchell Levinson to Board of DirectorsPulse Biosciences Appoints Mitchell Levinson to Board of Directors
finance.yahoo.com - March 19 at 9:41 AM
Pulse Biosciences IncPulse Biosciences Inc
www.bloomberg.com - March 18 at 6:45 PM
Pulse Biosciences Grants Equity Incentive Awards to New Employees - Business WirePulse Biosciences Grants Equity Incentive Awards to New Employees - Business Wire
www.businesswire.com - March 17 at 8:58 AM
Pulse Biosciences Announces Late Breaking Oral Presentation of Sebaceous Hyperplasia Study Results at the 2019 AAD Annual MeetingPulse Biosciences Announces Late Breaking Oral Presentation of Sebaceous Hyperplasia Study Results at the 2019 AAD Annual Meeting
finance.yahoo.com - March 1 at 9:42 AM
Pulse Bio files U.S. marketing application for CellFX systemPulse Bio files U.S. marketing application for CellFX system
seekingalpha.com - February 28 at 6:13 PM
Pulse Biosciences Submits 510(K) to U.S. FDA for CellFX™ SystemPulse Biosciences Submits 510(K) to U.S. FDA for CellFX™ System
finance.yahoo.com - February 28 at 6:13 PM
Pulse Biosciences, Inc. (PLSE) Q4 2018 Earnings Conference Call TranscriptPulse Biosciences, Inc. (PLSE) Q4 2018 Earnings Conference Call Transcript
finance.yahoo.com - February 15 at 9:50 AM
Pulse Biosciences Quarterly Investor ConferenceCallPulse Biosciences Quarterly Investor ConferenceCall
www.marketwatch.com - February 7 at 5:47 PM
Pulse Biosciences to Report Fourth Quarter and Full Year 2018 Operational Highlights and Financial ResultsPulse Biosciences to Report Fourth Quarter and Full Year 2018 Operational Highlights and Financial Results
finance.yahoo.com - January 29 at 9:21 AM
Pulse Biosciences Announces Two Appointments Focused on CellFX™ Commercialization: Promotion of Edward Ebbers and Addition of Robert TysonPulse Biosciences Announces Two Appointments Focused on CellFX™ Commercialization: Promotion of Edward Ebbers and Addition of Robert Tyson
finance.yahoo.com - January 17 at 5:29 PM
Pulse Biosciences Announces Positive Clinical Results of Its Nano-Pulse Stimulation™ Technology Platform to Treat Patients with Sebaceous Hyperplasia Lesions on the FacePulse Biosciences Announces Positive Clinical Results of Its Nano-Pulse Stimulation™ Technology Platform to Treat Patients with Sebaceous Hyperplasia Lesions on the Face
finance.yahoo.com - January 7 at 9:11 AM
How Many Insiders Bought Pulse Biosciences, Inc. (NASDAQ:PLSE) Shares?How Many Insiders Bought Pulse Biosciences, Inc. (NASDAQ:PLSE) Shares?
finance.yahoo.com - December 25 at 4:37 PM
Proposed Subscription to Raise $25m and Notice of General Meeting - GlobeNewswireProposed Subscription to Raise $25m and Notice of General Meeting - GlobeNewswire
globenewswire.com - December 17 at 9:18 AM
Pulse Biosciences, Inc. Announces Closing of Its $45 Million Rights Offering - Business WirePulse Biosciences, Inc. Announces Closing of Its $45 Million Rights Offering - Business Wire
www.businesswire.com - December 16 at 5:01 PM
Pulse Bio issues 3.6M common shares in rights offeringPulse Bio issues 3.6M common shares in rights offering
seekingalpha.com - December 14 at 4:56 PM
Pulse Biosciences, Inc. Announces Closing of Its $45 Million Rights OfferingPulse Biosciences, Inc. Announces Closing of Its $45 Million Rights Offering
finance.yahoo.com - December 14 at 4:56 PM
Investor Expectations to Drive Momentum within eBay, Pulse Biosciences, Evolus, Weibo, OptiNose, and The Descartes Systems Group — Discovering Underlying Factors of Influence - NasdaqInvestor Expectations to Drive Momentum within eBay, Pulse Biosciences, Evolus, Weibo, OptiNose, and The Descartes Systems Group — Discovering Underlying Factors of Influence - Nasdaq
www.nasdaq.com - December 11 at 5:03 PM
Pulse Biosciences, Inc. Announces Oversubscription, Pricing and Preliminary Results for Its $45 Million Rights OfferingPulse Biosciences, Inc. Announces Oversubscription, Pricing and Preliminary Results for Its $45 Million Rights Offering
finance.yahoo.com - December 7 at 4:52 PM
Pulse Biosciences, Inc. Announces Commencement of Rights OfferingPulse Biosciences, Inc. Announces Commencement of Rights Offering
www.businesswire.com - November 20 at 9:02 AM
Pulse Biosciences, Inc. Announces Commencement of Rights OfferingPulse Biosciences, Inc. Announces Commencement of Rights Offering
finance.yahoo.com - November 20 at 9:02 AM
Pulse Biosciences, Inc. Announces Record Date, Subscription Pricing, and Expiration Date for Rights Offering and Effectiveness of Its Registration StatementPulse Biosciences, Inc. Announces Record Date, Subscription Pricing, and Expiration Date for Rights Offering and Effectiveness of Its Registration Statement
finance.yahoo.com - November 8 at 9:17 AM
Pulse Biosciences, Inc. (PLSE) CEO Darrin Uecker on Q3 2018 Results - Earnings Call TranscriptPulse Biosciences, Inc. (PLSE) CEO Darrin Uecker on Q3 2018 Results - Earnings Call Transcript
seekingalpha.com - October 31 at 9:24 AM
Pulse Biosciences, Inc. (PLSE) Files Registration Statement for Rights OfferingPulse Biosciences, Inc. (PLSE) Files Registration Statement for Rights Offering
www.streetinsider.com - October 25 at 4:32 PM
Pulse Biosciences Files Registration Statement for Rights OfferingPulse Biosciences Files Registration Statement for Rights Offering
finance.yahoo.com - October 25 at 9:16 AM
Pulse Biosciences to Report Third Quarter 2018 and Operational Highlights and Financial ResultsPulse Biosciences to Report Third Quarter 2018 and Operational Highlights and Financial Results
finance.yahoo.com - October 23 at 4:26 PM
The Daily Biotech Pulse: Novartis Positive Liver Drug Trials, Krytstal Prices Offering, LogicBio To DebutThe Daily Biotech Pulse: Novartis Positive Liver Drug Trials, Krytstal Prices Offering, LogicBio To Debut
www.msn.com - October 19 at 9:26 AM
Pulse Biosciences, Inc. (PLSE) Reports Initiation of Clinical Feasibility Study for Nano-Pulse Stimulation PlatformPulse Biosciences, Inc. (PLSE) Reports Initiation of Clinical Feasibility Study for Nano-Pulse Stimulation Platform
www.streetinsider.com - October 13 at 8:46 AM
Pulse Biosciences initiates feasibility study to treat patients with cutaneous warts.Pulse Biosciences initiates feasibility study to treat patients with cutaneous warts.
seekingalpha.com - October 11 at 4:22 PM
Pulse Biosciences Announces Continued Expansion of Its Clinical Study Programs in DermatologyPulse Biosciences Announces Continued Expansion of Its Clinical Study Programs in Dermatology
finance.yahoo.com - October 11 at 8:56 AM
The Daily Biotech Pulse: Novartis Blood Disorder Drug Improves Patient Outcomes, Audentes To Offer SharesThe Daily Biotech Pulse: Novartis Blood Disorder Drug Improves Patient Outcomes, Audentes To Offer Shares
www.msn.com - October 10 at 9:06 AM
What Kind Of Risk Should You Expect For Pulse Biosciences Inc (NASDAQ:PLSE)?What Kind Of Risk Should You Expect For Pulse Biosciences Inc (NASDAQ:PLSE)?
finance.yahoo.com - October 9 at 4:22 PM
Pulse Biosciences to Present at the Cantor Global Healthcare ConferencePulse Biosciences to Present at the Cantor Global Healthcare Conference
finance.yahoo.com - October 2 at 9:06 AM
This page was last updated on 10/18/2019 by MarketBeat.com Staff

Featured Article: What is the NASDAQ?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel